Healthcare of Ontario Pension Plan Trust Fund Buys 19,000 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)

Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS) by 10.5% in the 1st quarter, HoldingsChannel reports. The fund owned 200,000 shares of the company’s stock after purchasing an additional 19,000 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Hims & Hers Health were worth $3,094,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the company. Certuity LLC acquired a new stake in Hims & Hers Health during the 4th quarter worth approximately $109,000. Belpointe Asset Management LLC lifted its holdings in shares of Hims & Hers Health by 10.0% during the fourth quarter. Belpointe Asset Management LLC now owns 13,238 shares of the company’s stock worth $118,000 after buying an additional 1,205 shares in the last quarter. Custom Index Systems LLC acquired a new stake in shares of Hims & Hers Health during the fourth quarter worth $132,000. B. Riley Wealth Advisors Inc. bought a new stake in shares of Hims & Hers Health in the fourth quarter valued at about $155,000. Finally, Avantax Advisory Services Inc. acquired a new position in shares of Hims & Hers Health in the first quarter valued at about $156,000. Institutional investors own 63.52% of the company’s stock.

Insider Activity

In other Hims & Hers Health news, insider Soleil Boughton sold 2,503 shares of the business’s stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $12.56, for a total transaction of $31,437.68. Following the sale, the insider now directly owns 161,860 shares of the company’s stock, valued at approximately $2,032,961.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO Andrew Dudum sold 188,888 shares of the stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $12.54, for a total value of $2,368,655.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Soleil Boughton sold 2,503 shares of the firm’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $12.56, for a total transaction of $31,437.68. Following the transaction, the insider now owns 161,860 shares of the company’s stock, valued at approximately $2,032,961.60. The disclosure for this sale can be found here. Insiders sold 983,988 shares of company stock valued at $18,635,842 over the last quarter. 17.71% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. Seaport Res Ptn reissued a “buy” rating on shares of Hims & Hers Health in a report on Friday, April 26th. Piper Sandler increased their price target on Hims & Hers Health from $16.00 to $18.00 and gave the stock a “neutral” rating in a research report on Thursday, July 11th. Bank of America lifted their price objective on Hims & Hers Health from $22.00 to $26.00 and gave the company a “buy” rating in a report on Thursday, June 13th. Citigroup lowered Hims & Hers Health from a “buy” rating to a “neutral” rating and increased their target price for the stock from $16.00 to $20.00 in a report on Wednesday, May 22nd. Finally, Truist Financial raised their price target on Hims & Hers Health from $13.00 to $23.00 and gave the stock a “hold” rating in a research report on Thursday, July 18th. Seven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.07.

Hims & Hers Health Price Performance

Shares of NYSE:HIMS opened at $23.26 on Friday. Hims & Hers Health, Inc. has a one year low of $5.65 and a one year high of $25.74. The firm has a 50 day simple moving average of $20.92 and a 200 day simple moving average of $15.15.

Hims & Hers Health (NYSE:HIMS) last announced its quarterly earnings results on Monday, May 6th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. The company had revenue of $278.20 million during the quarter, compared to analysts’ expectations of $270.37 million. Hims & Hers Health had a negative return on equity of 0.70% and a negative net margin of 0.24%. Hims & Hers Health’s revenue was up 45.8% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.05) EPS. Sell-side analysts forecast that Hims & Hers Health, Inc. will post 0.2 EPS for the current fiscal year.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.